adult screening programme
Glaucoma
Glaucoma is the name given to a group of eye conditions that affect vision. Glaucoma often affects both eyes, usually in varying degrees. One eye may develop glaucoma quicker than the other. If glaucoma is left untreated it can cause blindness. However, if it's diagnosed and treated early enough, further damage to your vision can be prevented.
Read more about glaucoma on the NHS website.
UK NSC screening recommendation
The UK NSC does not currently recommend screening for glaucoma in adults. This is because:
- it is not clear if the tests which are available are accurate enough to use in a screening programme
- outcomes for people with OAG compared to current treatment.
Supporting documents from the 2019 review
Evidence summary glaucoma (2019)
This document provides the evidence on which the current UK NSC recommendation is based.
UK NSC coversheet & consultation responses Glaucoma (2019)
This document summarises the review process including the public consultation comments.
Review cycle
Date previous review completed: 2019
Next review estimated to be completed: 2022 to 2023.
To see previous evidence reviews, visit the UK NSC archive.
Organisations interested in Glaucoma
These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
List of organisations
- Age UK
- Association for Independent Optometrists and Dispensing Opticians
- Association of Optometrists
- British and Irish Orthoptic Society
- British Association of Retinal Screening
- College of Optometrists
- Faculty of Public Health
- International Glaucoma Association
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Ophthalmologists
- Royal College of Ophthalmologists
- Royal College of Physicians
- Royal College of Physicians and Surgeons of Glasgow
- Royal College of Physicians of Edinburgh
- Royal National Institute of Blind People (RNIB)
- Sight Research UK
- Vision2020UK
If you think your organisation should be added, please contact us.